Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC

Name: Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC
Published: 2005
License: Public Domain

Memorial Sloan Kettering Cancer Center · 2005

ClinicalTrials.gov · Datasets · License: Public Domain · 2005

Open Source ↗

carcinoma

carcinoma, non-small-cell lung, multi-modality treatment for lung cancer, carcinoma, squamous cell, bevacizumab, beacon, 05-052, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC

Related documents